UBS AM’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.9K Sell
3,488
-179,067
-98% -$2.47M ﹤0.01% 2957
2026
Q1
$2.69M Buy
182,555
+6,586
+4% +$108K ﹤0.01% 1893
2025
Q4
$2.27M Sell
175,969
-14,675
-8% -$155K ﹤0.01% 1839
2025
Q3
$1.61M Sell
190,644
-102,316
-35% -$965K ﹤0.01% 1836
2025
Q2
$2.53M Buy
292,960
+82,056
+39% +$609K ﹤0.01% 2043
2025
Q1
$1.82M Buy
210,904
+6,747
+3% +$48K ﹤0.01% 2034
2024
Q4
$1.37M Buy
204,157
+35,948
+21% +$267K ﹤0.01% 2224
2024
Q3
$1.21M Buy
168,209
+70,498
+72% +$649K ﹤0.01% 2300
2024
Q2
$1.02M Sell
97,711
-9,161
-9% -$91.5K ﹤0.01% 2363
2024
Q1
$1.07M Buy
106,872
+4,208
+4% +$45.2K ﹤0.01% 1973
2023
Q4
$1.57M Sell
102,664
-208
-0.2% -$2.87K ﹤0.01% 1796
2023
Q3
$1.44M Sell
102,872
-21,848
-18% -$330K ﹤0.01% 1777
2023
Q2
$2.01M Hold
124,720
﹤0.01% 1639
2023
Q1
$2.01M Buy
124,720
+2,143
+2% +$37.9K ﹤0.01% 1639
2022
Q4
$1.82M Buy
122,577
+1,476
+1% +$25.7K ﹤0.01% 1566
2022
Q3
$2.41M Sell
121,101
-30,533
-20% -$756K ﹤0.01% 1503
2022
Q2
$3.1M Sell
151,634
-37,588
-20% -$929K ﹤0.01% 1419
2022
Q1
$5.74M Buy
189,222
+845
+0.4% +$33K ﹤0.01% 1297
2021
Q4
$7.71M Buy
188,377
+2,727
+1% +$113K ﹤0.01% 1225
2021
Q3
$7.87M Buy
185,650
+16,056
+9% +$794K ﹤0.01% 1178
2021
Q2
$8.94M Buy
169,594
+9,749
+6% +$485K ﹤0.01% 1163
2021
Q1
$7.09M Sell
159,845
-116,875
-42% -$5.76M ﹤0.01% 1200
2020
Q4
$13.3M Buy
276,720
+39,954
+17% +$1.93M 0.01% 959
2020
Q3
$11M Buy
236,766
+54,053
+30% +$2.65M 0.01% 918
2020
Q2
$8.22M Sell
182,713
-12,611
-6% -$490K 0.01% 966
2020
Q1
$5.7M Buy
195,324
+17,048
+10% +$635K ﹤0.01% 1011
2019
Q4
$8.5M Buy
178,276
+14,758
+9% +$639K 0.01% 998
2019
Q3
$6.19M Buy
163,518
+420
+0.3% +$16.4K ﹤0.01% 1125
2019
Q2
$6.97M Buy
163,098
+8,383
+5% +$397K 0.01% 1079
2019
Q1
$8.2M Buy
154,715
+3,148
+2% +$181K 0.01% 984
2018
Q4
$8.93M Sell
151,567
-418
-0.3% -$23.1K 0.01% 910
2018
Q3
$8.29M Buy
151,985
+385
+0.3% +$21.3K 0.01% 980
2018
Q2
$8.14M Sell
151,600
-17,192
-10% -$904K 0.01% 993
2018
Q1
$8.23M Buy
168,792
+22,778
+16% +$967K 0.01% 983
2017
Q4
$4.94M Buy
146,014
+1,972
+1% +$69.1K ﹤0.01% 1122
2017
Q3
$4.89M Buy
144,042
+3,602
+3% +$123K ﹤0.01% 1097
2017
Q2
$5.01M Buy
140,440
+21,382
+18% +$721K ﹤0.01% 1040
2017
Q1
$3.46M Buy
119,058
+8,588
+8% +$239K ﹤0.01% 1128
2016
Q4
$2.66M Sell
110,470
-151,564
-58% -$4.14M ﹤0.01% 1173
2016
Q3
$8.12M Buy
262,034
+96,380
+58% +$3.04M 0.01% 922
2016
Q2
$4.85M Buy
165,654
+26,048
+19% +$780K 0.01% 1020
2016
Q1
$4.3M Sell
139,606
-21,726
-13% -$561K 0.01% 1060
2015
Q4
$4.33M Sell
161,332
-5,816
-3% -$162K ﹤0.01% 1122
2015
Q3
$4.55M Buy
167,148
+24,808
+17% +$680K 0.01% 1088
2015
Q2
$3.92M Sell
142,340
-193,026
-58% -$4.67M ﹤0.01% 1127
2015
Q1
$7.17M Sell
335,366
-612,428
-65% -$10.5M 0.01% 970
2014
Q4
$17.9M Sell
947,794
-168,126
-15% -$3.6M 0.02% 730
2014
Q3
$24.4M Buy
1,115,920
+181,802
+19% +$4.86M 0.02% 627
2014
Q2
$30.1M Buy
934,118
+132,494
+17% +$4.06M 0.03% 568
2014
Q1
$23M Buy
801,624
+63,204
+9% +$2.09M 0.02% 629
2013
Q4
$29.1M Sell
738,420
-87,900
-11% -$3.05M 0.03% 521
2013
Q3
$28.8M Sell
826,320
-43,428
-5% -$1.34M 0.04% 497
2013
Q2
$19.6M Buy
+869,748
New +$18.5M 0.03% 580

Other funds holding HLF

UBS AM's HLF Position: Q2 2026 in Review

UBS AM reduced its Herbalife (HLF) stake by 98% in Q2 2026, selling an estimated $2.47M and leaving 3,488 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

UBS AM first reported a position in HLF in Q2 2013 and has held it in 53 quarters since. The position peaked at $30.1M in Q2 2014. 234 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • UBS AM held 3,488 shares of Herbalife worth $45.9K as of Q2 2026.
  • UBS AM sold 179,067 Herbalife shares in Q2 2026, an estimated $2.47M.
  • Herbalife made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2957 holding.
  • UBS AM first reported a position in Herbalife in Q2 2013 and has held it in 53 quarters since.
  • UBS AM's Herbalife position peaked at $30.1M in Q2 2014.
  • 234 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.